India a autorizat în premieră pe piaţa sa internă utilizarea unui vaccin împotriva febrei denga, Qdenga, fabricat de un producător japonez, a anunţat Ministerul indian al Sănătăţii.

QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing.

Japanese drug firm Takeda Biopharmaceuticals has received market authorisation from the Drug Controller General of India (DCGI) for QDENGA, making it the first dengue vaccine…

India's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in India during the first half of 2027.…